# A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni

> **NCT01054651** · PHASE3 · COMPLETED · sponsor: **Kenya Medical Research Institute** · enrollment: 212 (actual)

## Conditions studied

- Schistosoma Mansoni

## Interventions

- **DRUG:** Artesunate+Sulfamethoxypyrazine/pyrimethamine
- **DRUG:** Praziquantel

## Key facts

- **NCT ID:** NCT01054651
- **Lead sponsor:** Kenya Medical Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2010-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01054651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01054651, "A Randomised Trial of Artesunate-sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel for the Treatment of S. Mansoni". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01054651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*